朴雪品牌怎么样 申请店铺

我要投票 朴雪在补铁锌硒行业中的票数:415 更新时间:2025-06-21
朴雪是哪个国家的品牌?「朴雪」是 哈药集团有限公司 旗下著名品牌。该品牌发源于黑龙江,由创始人徐志越在1989期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力朴雪品牌出海!将品牌入驻外推网,定制朴雪品牌推广信息,可以显著提高朴雪产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

朴雪怎么样

朴雪为哈药集团制药六厂旗下保健食品品牌,主要产品为朴雪乳酸亚铁口服液,适用于营养性贫血者,能有效改善营养性贫血。

哈药六厂是以生产化学药品及中成药为主,保健食品和"纯中纯"无菌纯净水系列、茶饮料系列为辅的综合制药企业,制剂手段完备,设备先进,可生产大容量注射剂、口服液、糖浆剂、片剂、胶囊剂、颗粒剂和原料药等,产品远销全国。主导产品:盖中盖系列保健食品、严迪、泻痢停、为消、护彤、丹王颗粒等畅销产品。1999年企业开始跨入保健食品生产企业行列。

哈药集团制药六厂(以下简称为“哈药六厂”)始建于1977年,1995年改制为国有控股的股份制企业,2006年改制为国有控股、中外合资企业,是以生产化学药品为主、以保健食品和饮品为辅的综合性企业。

建厂以后,企业长期处于低速发展状态,由于连年亏损,已濒临破产的边缘。1988年以后,全厂职工在调整后的厂级领导班子的正确领导下,团结协作,艰苦奋斗,在短短的二十多年的时间里使企业产生了裂变式的、超常规的发展,取得了令人瞩目的成绩,现已成为省、市政府的纳税大户和哈药集团的四大骨干企业之一,连续多年完成集团公司下达的各项经济技术指标。厂区占地为10万平方米,建筑面积达25万平方米。

企业生产设备先进完善,按照GMP标准要求,全面系统地改造了综合制剂生产车间、固体制剂生产车间及饮品综合生产车间,并全面通过GMP认证和相关验收。

药品生产剂型包括:原料药(人工牛黄)、片剂、胶囊剂、颗粒剂、口服液、糖浆剂、口服溶液剂、合剂(含中药提取);橡胶膏剂、膏药、软胶囊剂和巴布剂12个剂型170余种产品。

保健食品生产包括片剂、口服液两个剂型14种产品。

饮品生产包括饮用纯净水、茶饮料、果汁系列等11种产品。

主导产品有严迪牌罗红霉素分散片、护彤牌小儿氨酚黄那敏颗粒、泻利停牌颠茄磺苄啶片、为消牌乳酸菌素片、新盖中盖牌高钙片、哈药六牌钙加锌口服液、朴雪乳酸亚铁口服液、新盖中盖牌乳酸钙口服液及纯中纯系列饮品等。

Park snow is a brand of health food under the sixth pharmaceutical factory of Harbin Pharmaceutical Group. Its main product is park snow ferrous lactate oral liquid, which is suitable for the patients with nutritional anemia and can effectively improve nutritional anemia. Harbin No.6 Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise mainly engaged in the production of chemicals and Chinese patent medicines, supplemented by health food and "pure and medium" aseptic pure water series and tea beverage series. With complete preparation means and advanced equipment, it can produce large volume injections, oral liquids, syrups, tablets, capsules, granules and APIs. Its products are sold all over the country. Leading products: gaizhonggai series of health food, Yandi, XIELITING, Weixiao, Hutong, Danwang granules and other best-selling products. In 1999, enterprises began to enter the ranks of health food production enterprises. Harbin Pharmaceutical Group Pharmaceutical No.6 factory (hereinafter referred to as "Harbin Pharmaceutical No.6 factory") was founded in 1977, restructured into a state-owned holding joint-stock enterprise in 1995 and a state-owned holding and Sino foreign joint venture in 2006. It is a comprehensive enterprise mainly engaged in the production of chemicals, supplemented by health food and drinks. After the establishment of the factory, the enterprise has been in a state of low-speed development for a long time. Because of years of losses, it is on the verge of bankruptcy. After 1988, under the correct leadership of the adjusted leading group at the factory level, the employees of the whole plant united and cooperated with each other and worked hard. In a short period of more than 20 years, the enterprise had a fission and unconventional development, and made remarkable achievements. Now it has become one of the four backbone enterprises of the provincial and municipal governments and Harbin Pharmaceutical Group, and has completed the group's corporate governance for many years in a row Economic and technical indicators issued by the division. The factory covers an area of 100000 square meters, with a building area of 250000 square meters. The production equipment of the enterprise is advanced and perfect. According to the requirements of GMP standard, the comprehensive preparation production workshop, solid preparation production workshop and beverage comprehensive production workshop have been comprehensively and systematically reformed, and have passed GMP certification and relevant acceptance. Drug production dosage forms include: raw material drug (artificial bezoar), tablet, capsule, granule, oral liquid, syrup, oral solution, mixture (including extraction of traditional Chinese Medicine); rubber plaster, plaster, soft capsule and cataplasm 12 dosage forms of 170 kinds of products. The production of health food includes 14 kinds of products in two dosage forms: tablet and oral liquid. The beverage production includes 11 kinds of products such as drinking pure water, tea beverage, juice series, etc. The main products are Yandi brand roxithromycin dispersible tablets, Houtong brand Xiaoer aminophenol huangnamin granules, XIELITING brand belladonna sulfonylbenzylidine tablets, Weixiao brand Lactobacillin tablets, xingaizhonggai brand high calcium tablets, Harbin medicine Liupai calcium and zinc oral liquid, Puxue ferrous lactate oral liquid, xingaizhonggai brand calcium lactate oral liquid and pure medium pure series drinks, etc.

本文链接: https://brand.waitui.com/43a43fa04.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

钱曦获批担任珠海华润银行董事长

6月20日,广东金融监管局网站发布批复,核准钱曦珠海华润银行股份有限公司董事长的任职资格。该行应要求上述核准任职资格人员严格遵守金融监管总局有关监管规定,自本行政许可决定作出之日起3个月内到任,并按要求在到任后10日内报告到任情况。未在上述规定期限内到任的,本批复文件失效,由决定机关办理行政许可注销手续。(界面新闻)

21分钟前

宇石空间:AS-1火箭二级全箭管路完成鉴定振动试验,全箭正式进入总装阶段

36氪获悉,昨日晚间宇石空间宣布已攻克AS-1运载火箭二级全箭管路设计、制造和试验验证难题,考核多种复杂载荷工况综合作用:振动+压力+低温联合试验,圆满完成了火箭二级全箭管路鉴定振动试验。试验数据显示,所有被测管路在多种飞行工况产生的极端环境下,结构和气密性良好,完全符合设计要求。这意味着 AS-1 火箭全箭正式步入总装阶段,为后续AS-1火箭二子级静态点火试验奠定了坚实基础。

21分钟前

欧盟中国商会声明:反对欧委会IPI下排除中企参与医疗器械公共采购

36氪获悉,6月20日,欧委会宣布在《国际采购工具》(IPI)首个调查后,排除中企在欧盟参与相关公共采购,并要求中标项目中来自中国的产品及零部件比例不得超过50%。6月21日,欧盟中国商会发布声明称对欧方这一单边保护主义做法、欧方公开对中企采取不公平的歧视性措施表示坚决反对。 欧盟中国商会认为,欧方IPI调查结果并不公允,其“大部分中方医疗公共采购市场排除或歧视欧盟制造的医疗器械及欧盟供应商”结论不符合实际。此外,中国与欧盟在内的贸易伙伴长期就GPA及公共采购问题保持磋商,双向沟通渠道始终畅通。在此背景下,欧方选择仓促地付诸单边措施,令业界十分失望。 欧盟中国商会表示,欧方通过IPI排除中企出医疗采购公共采购,以及增加本地化要求的做法对中国相关产品以及中国供应商严重的歧视性和排他性措施,我们对欧方这一扭曲公平竞争市场环境的做法表示坚决反对,对其对中欧在医疗领域贸易及投资关系发展所带来的冲击表示严正关切。 欧盟中国商会呼吁欧方立即停止这一错误做法,为在欧医疗领域中企提供公平、公正和非歧视性的营商环境。

21分钟前

月之暗面Kimi首个Agent开启内测

6月20日晚间,月之暗面宣布其第一个Agent开启内测。Kimi-Researcher(深度研究)是通过端到端强化学习训练出来的Agent模型,即日起开始小范围灰度测试。月之暗面表示,将逐步开源Kimi-Researcher基础预训练模型、以及强化学习后的模型。(界面新闻)

21分钟前

老铺黄金新加坡首店开业

36氪获悉,6月21日,老铺黄金新加坡店正式开业,该店是老铺黄金在海外市场的首个店铺,被市场普遍认为是老铺黄金全球化扩张的关键一步。据了解,新店位于新加坡地标性高端商业体滨海湾金沙,毗邻路易威登、爱马仕等一众国际奢侈品品牌。

21分钟前

本页详细列出关于朴雪的品牌信息,含品牌所属公司介绍,朴雪所处行业的品牌地位及优势。
咨询